Wolverine Trading, LLC Novo Cure LTD Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $198,247 - $296,418	-12,700 Reduced 32.23%	26,700 $417,000
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $111,202 - $226,070	9,400 Added 31.33%	39,400 $674,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $21,114 - $29,393	1,700 Added 6.01%	30,000 $468,000
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $138,012 - $195,672	-12,400 Reduced 30.47%	28,300 $422,000
Q3 2023 Nov 15, 2023	BUY	$16.15 - $42.35 $25,839 - $67,760	1,600 Added 4.09%	40,700 $657,000
Q2 2023 Aug 23, 2023	BUY	$40.29 - $82.51 $721,191 - $1.48 Million	17,900 Added 84.43%	39,100 $1.62 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $1.11 Million - $2.33 Million	-19,600 Reduced 48.04%	21,200 $1.24 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $569,422 - $759,793	8,900 Added 27.9%	40,800 $2.99 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $156,377 - $206,010	2,300 Added 7.77%	31,900 $2.46 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $147,160 - $233,740	2,600 Added 9.63%	29,600 $2.14 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $2.59 Million - $3.63 Million	-43,000 Reduced 61.43%	27,000 $2.27 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $473,004 - $768,537	-6,300 Reduced 8.26%	70,000 $5.59 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $929,360 - $1.56 Million	8,000 Added 11.71%	76,300 $8.86 Million
Q2 2021 Aug 06, 2021	SELL	$130.4 - $225.58 $5.58 Million - $9.65 Million	-42,800 Reduced 38.52%	68,300 $15.3 Million
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $13.8 Million - $21.1 Million	111,100 New	111,100 $13.9 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $17.3 Million - $26.8 Million	-153,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $4.56 Million - $8.74 Million	78,500 Added 104.25%	153,800 $16.8 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $4.8 Million - $6.25 Million	-84,000 Reduced 52.73%	75,300 $4.35 Million
Q1 2020 May 11, 2020	SELL	$57.05 - $95.75 $2.26 Million - $3.79 Million	-39,600 Reduced 19.91%	159,300 $11.2 Million
Q4 2019 Feb 12, 2020	SELL	$68.3 - $93.8 $6.43 Million - $8.84 Million	-94,200 Reduced 32.14%	198,900 $17 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $12.1 Million - $19.2 Million	196,200 Added 202.48%	293,100 $21.5 Million
Q2 2019 Aug 20, 2019	BUY	$42.22 - $63.23 $4.09 Million - $6.13 Million	96,900 New	96,900 $6.13 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $2.59 Million - $4.55 Million	-81,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $2.74 Million - $5.03 Million	-95,500 Reduced 54.11%	81,000 $2.66 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $3.6 Million - $5.9 Million	112,500 Added 175.78%	176,500 $9.25 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $301,080 - $368,940	-15,600 Reduced 19.6%	64,000 $1.4 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $1.3 Million - $1.74 Million	79,600	79,600 $1.61 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account